&agr;&ngr;&bgr;3 integrin antagonists in combination with chemotherapeutic agents
US6372719B1 · kind B1 · utility
12Cited by
1References
13Claims
0Family size
Inventors
Key dates
| Filing date | Mar 4, 1999 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Mar 4, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of the formula and pharmaceutically acceptable salts and isomers thereof administered in combination with chemotherapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.